In 2024, Wegovy received additional approval for lowering cardiovascular risk, and Zepbound was approved for treating moderate to severe obstructive sleep apnea in adults with obesity or who are overweight
Common side effects include nausea, diarrhea, or constipation, which tend to be mild and temporary
The peptide combination approach Rather than viewing research peptides as standalone tirzepatide replacements, many researchers approach them as components of a multi-modal protocol
The best results occur when: Treatment is personalized Dosage is medically controlled Expectations are realistic Lifestyle supports skin health At Regain Aesthetic Clinic , we prioritize patient education, safety, and natural-looking outcomes
It is reassuring to note that clinical trial data from the STEP programme (using dual-energy X-ray absorptiometry) indicate that fat loss predominates with semaglutide 2.4 mg